Show simple item record

THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT

dc.contributor.authorElverdi, T.
dc.contributor.authorAydin, Y.
dc.contributor.authorBaslar, Z.
dc.contributor.authorBerk, S.
dc.contributor.authorOzbek, U.
dc.contributor.authorTuzuner, N.
dc.contributor.authorAr, M. C.
dc.contributor.authorSalihoglu, A.
dc.contributor.authorSoysal, T.
dc.contributor.authorYalniz, F. F.
dc.contributor.authorErdogan, I.
dc.contributor.authorAydin, S. Ongoren
dc.contributor.authorEskazan, A. E.
dc.contributor.authorSadri, S.
dc.date.accessioned2021-03-02T20:48:28Z
dc.date.available2021-03-02T20:48:28Z
dc.identifier.citationSoysal T., Eskazan A. E. , Sadri S., Erdogan I., Berk S., Yalniz F. F. , Elverdi T., Salihoglu A., Ar M. C. , Aydin S. O. , et al., "THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT", 20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.447
dc.identifier.otherav_03bde1ff-ad3e-4efd-a2f9-e96d657241de
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/8460
dc.language.isoeng
dc.subjectHEMATOLOJİ
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHematoloji
dc.subjectİç Hastalıkları
dc.titleTHE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume100
dc.contributor.firstauthorID146913


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record